Advertisement

Venetoclax

Tumour lysis syndrome following off-label use: 5 case reports

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Hughes ME, et al. Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use. Clinical Lymphoma, Myeloma & Leukemia 19: 791-798, No. 12, Dec 2019. Available from: URL: https://doi.org/10.1016/j.clml.2019.09.612

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Venetoclax. Reactions Weekly 1786, 160 (2020) doi:10.1007/s40278-020-73634-1

    Download citation